Response
Dr Cheng is absolutely correct in pointing out the distinction between the generic name warfarin and the trade name Coumadin. The original Organization to Assess Strategies for Ischemic Syndromes (OASIS) pilot study article 1 correctly used the term warfarin throughout, but it did not specify the drug supplier. My letter 2 did not.
For readers interested in learning more about the history of drug development, including aspirin, heparin, warfarin, and thrombolytic agents, a review by Mueller and Schneidt 3 provides a wonderful overview. I promise to reread it.
